Drug Importation By the Numbers

When broken down to the nuts and bolts of implementation and operational execution, currently proposed drug importation plans fall apart. Drug Importation is neither a safe nor cost-effective solution.  The numbers do not lie.

References

• House testimony in energy and commerce by Carol Cave, FDA, July 16, 2019: https://www.fda.gov/news-events/congressional-testimony/oversight-federal-efforts-combat-spread-illicit-fentanyl-07162019
• The risks and realities of commercial drug importation HDA Research Foundation, July 2019: https://www.hda.org/resources/the-risks-and-realities-of-commercial-drug-importation
• Drug Importation Endangers U.S. Patients By Breaking Our Closed, Secure Drug Supply: https://www.safemedicines.org/policymakers-media
• Deadly Fentanyl-Laced Counterfeit Pills Have Spread To 46 States In The Last Two And A Half Years, February 20, 2019: https://www.safemedicines.org/2019/02/pills-in-46-states.html